Adding to the Mix: Fibroblast Growth Factor and Platelet-Derived Growth Factor Receptor Pathways as Targets in Non-small Cell Lung Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|12|2|107-123

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.12, Iss.2, 2012-02, pp. : 107-123

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epidermal Growth Factor Receptor Inhibitors in Non-Small Cell Lung Cancer

By Dancey Janet E.  

Drugs, Vol. 67, Iss. 8, 2007-01 ,pp. : 1125-1138

Adis International

Access to resources Recommend Favorite

Optimal Management of Patients with Non-Small Cell Lung Cancer and Epidermal Growth Factor Receptor Mutations

By Lin Chia-Chi   Yang James Chih-Hsin  

Drugs, Vol. 71, Iss. 1, 2011-01 ,pp. : 79-88

Adis International

Access to resources Recommend Favorite

Epidermal growth factor receptor inhibitors in the treatment of non-small cell lung cancer

By Agelaki Sofia   Georgoulias Vassilis  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 4, 2005-11 ,pp. : 855-874

Informa Healthcare

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor Targeting in Non-Small Cell Lung Cancer: Revisiting Different Strategies Against the Same Target

By  

Current Drug Targets, Vol. 15, Iss. 14, 2014-12 ,pp. : 1273-1283

Bentham Science Publishers

Access to resources Recommend Favorite

The potential role of insulin-like growth factor receptor inhibitors in the treatment of advanced non-small cell lung cancer

By Gridelli Cesare   Rossi Antonio   Bareschino Maria Anna   Schettino Clorinda   Sacco Paola Claudia   Maione Paolo  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 5, 2010-05 ,pp. : 631-639

Informa Healthcare

Access to resources Recommend Favorite